Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)

NCT04826172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemia
Coronary Artery Disease

Interventions

DRUG: IMB-1018972
DRUG: Placebo

Sponsor

Imbria Pharmaceuticals, Inc.